A high-fat diet decreases AMPK activity in multiple tissues in the absence of hyperglycemia or systemic inflammation

Christopher R Lindholm1, Rebecca L Ertel, Jake D Bauwens

  • 1Department of Medicine, Division of Cardiovascular Medicine, University of Wisconsin, 1630 Medical Sciences Center, Madison, WI 53706, USA.

Insights

A high-fat diet (HFD) significantly reduces AMP-activated protein kinase (AMPK) activity across key tissues, contributing to obesity and insulin resistance. This HFD-induced decrease in AMPK activity may play a crucial role in metabolic syndrome development.

Area of Science:

  • Metabolic research
  • Molecular biology
  • Obesity studies

Background:

  • High-fat diets (HFD) induce obesity and insulin resistance, mimicking human metabolic syndrome.
  • The precise molecular events linking HFD to pathology are often unclear.
  • AMP-activated protein kinase (AMPK) is a critical regulator of cellular metabolism and energy balance.

Purpose of the Study:

  • To investigate the relationship between HFD and AMPK activity in various tissues.
  • To elucidate the role of AMPK in HFD-induced obesity and metabolic dysfunction.

Main Methods:

  • Animal models fed a HFD.
  • Measurement of AMPK activity in white adipose tissue, heart, liver, granulocytes, and agranulocytes.
  • Assessment of systemic inflammation, hyperglycemia, and free fatty acid levels.

Main Results:

  • HFD significantly decreased AMPK activity in white adipose tissue, heart, and liver.
  • These decreases occurred without changes in AMPK transcription, systemic inflammation, hyperglycemia, or elevated free fatty acids.
  • HFD-induced decrease in AMPK activity correlated with insulin resistance and hyperleptinemia.
  • AMPK activity in blood cells (granulocytes and agranulocytes) remained unaltered by HFD.

Conclusions:

  • HFD-induced obesity leads to a widespread reduction in AMPK activity, independent of tissue or specific isoform.
  • Reduced AMPK activity may represent a novel contributing factor to obesity and associated metabolic pathologies.